Tolerance: definition, mechanism, time course, implications, treatment
Dependence: definition and types, associations, cause, risk factors, withdrawal, treatment
Definition |
· Reduced intensity and duration of effect of a given dose of opioid with chronic use · No change in efficacy · i.e. Right shift in log(dose) response curve · Occurs to variable extent |
Representation |
(individual graded log-dose response curve) |
Mechanisms |
· Receptor downregulation (β-arrestin binds COOH terminal of phosphorylated activated G-protein coupled receptor, triggering downregulation and destruction) · Change in receptor effect (Gi -> quasi Gs) · Upregulation of cAMP system · ↑NMDA activity (↓NMDA transport -> ↑synaptic [glutamate] -> tolerance and opioid-induced hyperalgaesia) |
Time course |
· Onset and offset rapid for inhibitory effects (analgesia, respiratory depression) · Onset and offset slow for excitatory effects (miosis, constipation) |
Implications of time course |
· Use of previously effective dose after a short layoff may cause overdose and death · Patients with chronic pain on opioids require very high dose for same effect o Hence more GIT side effects o Hence importance of use of adjuvants e.g. ketamine |
Treatment |
· Opioid rotation · Opioid weaning, esp with ketamine infusion (‘re-sets’ opioid receptors) |
Definition |
· Reliance on drug for normal functioning · Physical: withdrawal symptoms on cessation · Psychological: craving for drug on cessation |
Associated features |
· Dependent patients often tolerant; tolerant patients not always dependent · Addiction (harmful drug-seeking behavior) – especially if psychological dependence |
Cause |
· As for tolerance · Pathological adaptation in dopaminergic reward pathways |
Risk factors |
· Drug characteristics: o Rapid onset (high lipid solubility, high % unionised (e.g. alfentanil) o Highly euphoric (e.g. diacetylmorphine) · Administration: prolonged use (e.g. chronic pain) · Patient: psychiatric history, unemployment etc. |
Withdrawal features |
· Physical: nausea, sweating, cholinergic (salivation, lacrimation, GIT cramp) · Psychological: craving, dysphoria, restlessness, insomnia |
Treatment |
· Opioid replacement (e.g. methadone, buprenorphine/naloxone) · Psychosocial intervention |
Feedback welcome at ketaminenightmares@gmail.com